418 related articles for article (PubMed ID: 16962608)
1. Dimerisation strategies for shark IgNAR single domain antibody fragments.
Simmons DP; Abregu FA; Krishnan UV; Proll DF; Streltsov VA; Doughty L; Hattarki MK; Nuttall SD
J Immunol Methods; 2006 Aug; 315(1-2):171-84. PubMed ID: 16962608
[TBL] [Abstract][Full Text] [Related]
2. Rapid isolation of IgNAR variable single-domain antibody fragments from a shark synthetic library.
Shao CY; Secombes CJ; Porter AJ
Mol Immunol; 2007 Jan; 44(4):656-65. PubMed ID: 16500706
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies for the identification and purification of vNAR domains and IgNAR immunoglobulins from the horn shark Heterodontus francisci.
Juarez K; Dubberke G; Lugo P; Koch-Nolte F; Buck F; Haag F; Licea A
Hybridoma (Larchmt); 2011 Aug; 30(4):323-9. PubMed ID: 21851231
[TBL] [Abstract][Full Text] [Related]
4. Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1.
Nuttall SD; Humberstone KS; Krishnan UV; Carmichael JA; Doughty L; Hattarki M; Coley AM; Casey JL; Anders RF; Foley M; Irving RA; Hudson PJ
Proteins; 2004 Apr; 55(1):187-97. PubMed ID: 14997552
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
6. Dissection of the IgNAR V domain: molecular scanning and orthologue database mining define novel IgNAR hallmarks and affinity maturation mechanisms.
Fennell BJ; Darmanin-Sheehan A; Hufton SE; Calabro V; Wu L; Müller MR; Cao W; Gill D; Cunningham O; Finlay WJ
J Mol Biol; 2010 Jul; 400(2):155-70. PubMed ID: 20450918
[TBL] [Abstract][Full Text] [Related]
7. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.
Arndt KM; Müller KM; Plückthun A
J Mol Biol; 2001 Sep; 312(1):221-8. PubMed ID: 11545598
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of an IgNAR variable domain specific for the human mitochondrial translocase receptor Tom70.
Nuttall SD; Krishnan UV; Doughty L; Pearson K; Ryan MT; Hoogenraad NJ; Hattarki M; Carmichael JA; Irving RA; Hudson PJ
Eur J Biochem; 2003 Sep; 270(17):3543-54. PubMed ID: 12919318
[TBL] [Abstract][Full Text] [Related]
9. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a shark single-domain antibody V region in complex with lysozyme.
Stanfield RL; Dooley H; Flajnik MF; Wilson IA
Science; 2004 Sep; 305(5691):1770-3. PubMed ID: 15319492
[TBL] [Abstract][Full Text] [Related]
11. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
Nielsen UB; Adams GP; Weiner LM; Marks JD
Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
[TBL] [Abstract][Full Text] [Related]
12. Humanization of an agonistic anti-death receptor 4 single chain variable fragment antibody and avidity-mediated enhancement of its cell death-inducing activity.
Lee SH; Park DW; Sung ES; Park HR; Kim JK; Kim YS
Mol Immunol; 2010 Jan; 47(4):816-24. PubMed ID: 19864027
[TBL] [Abstract][Full Text] [Related]
13. Recognition of DNA by VH and Fv domains of an IgG anti-poly(dC) antibody with a singly mutated VH domain.
O'Connor KC; Nguyen K; Stollar BD
J Mol Recognit; 2001; 14(1):18-28. PubMed ID: 11180559
[TBL] [Abstract][Full Text] [Related]
14. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
Kalinke U; Krebber A; Krebber C; Bucher E; Plückthun A; Zinkernagel RM; Hengartner H
Eur J Immunol; 1996 Dec; 26(12):2801-6. PubMed ID: 8977271
[TBL] [Abstract][Full Text] [Related]
15. Overview and discovery of IgNARs and generation of VNARs.
Nuttall SD
Methods Mol Biol; 2012; 911():27-36. PubMed ID: 22886244
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries.
Goodchild SA; Dooley H; Schoepp RJ; Flajnik M; Lonsdale SG
Mol Immunol; 2011 Sep; 48(15-16):2027-37. PubMed ID: 21752470
[TBL] [Abstract][Full Text] [Related]
17. Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen.
Rheinnecker M; Hardt C; Ilag LL; Kufer P; Gruber R; Hoess A; Lupas A; Rottenberger C; Plückthun A; Pack P
J Immunol; 1996 Oct; 157(7):2989-97. PubMed ID: 8816407
[TBL] [Abstract][Full Text] [Related]
18. Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library.
Liu JL; Anderson GP; Delehanty JB; Baumann R; Hayhurst A; Goldman ER
Mol Immunol; 2007 Mar; 44(7):1775-83. PubMed ID: 17007931
[TBL] [Abstract][Full Text] [Related]
19. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis, selection, and ontogeny of the shark new antigen receptor (IgNAR): identification of a new locus preferentially expressed in early development.
Diaz M; Stanfield RL; Greenberg AS; Flajnik MF
Immunogenetics; 2002 Oct; 54(7):501-12. PubMed ID: 12389098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
